Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Varani

Showing results (41-50 of 239) with videos related to

Pageof 24
Sort By:
Pharmacology & Therapeutics|November 22, 2007
The A3 adenosine receptor: an enigmatic player in cell biologyStefania Gessi, Stefania Merighi, Katia Varani, et al.
Frontiers in Oncology|October 18, 2021
A<sub>3</sub> Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural MesotheliomaFabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, et al.
Current Medicinal Chemistry|November 30, 2021
A<sub>2A</sub> Adenosine Receptor Antagonists in Neurodegenerative DiseasesStefania Merighi, Pier A Borea, Katia Varani, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Expert Opinion on Therapeutic Targets|June 14, 2019
Targeting A3 and A2A adenosine receptors in the fight against cancerStefania Merighi, Enrica Battistello, Luca Giacomelli, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 29, 2002
Synthesis and pharmacological evaluation of some (pyridyl)cyclopropylmethyl amines and their methiodides as nicotinic receptor ligandsLuca Guandalini, Silvia Dei, Dina Manetti, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
Arthritis and Rheumatism|October 1, 2009
Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexateKatia Varani, Alfonso Massara, Fabrizio Vincenzi, et al.
Biochemical Pharmacology|December 14, 2007
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptorsKatia Varani, Annmarie Surprenant, Fabrizio Vincenzi, et al.
Arthritis Research & Therapy|August 28, 2016
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosusAlessandra Bortoluzzi, Fabrizio Vincenzi, Marcello Govoni, et al.
Pageof 24

Showing results (41-50 of 239) with videos related to

Sort By:
Pageof 24
Pharmacology & Therapeutics|November 22, 2007
The A3 adenosine receptor: an enigmatic player in cell biologyStefania Gessi, Stefania Merighi, Katia Varani, et al.
Frontiers in Oncology|October 18, 2021
A<sub>3</sub> Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural MesotheliomaFabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, et al.
Current Medicinal Chemistry|November 30, 2021
A<sub>2A</sub> Adenosine Receptor Antagonists in Neurodegenerative DiseasesStefania Merighi, Pier A Borea, Katia Varani, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Expert Opinion on Therapeutic Targets|June 14, 2019
Targeting A3 and A2A adenosine receptors in the fight against cancerStefania Merighi, Enrica Battistello, Luca Giacomelli, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 29, 2002
Synthesis and pharmacological evaluation of some (pyridyl)cyclopropylmethyl amines and their methiodides as nicotinic receptor ligandsLuca Guandalini, Silvia Dei, Dina Manetti, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
Arthritis and Rheumatism|October 1, 2009
Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexateKatia Varani, Alfonso Massara, Fabrizio Vincenzi, et al.
Biochemical Pharmacology|December 14, 2007
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptorsKatia Varani, Annmarie Surprenant, Fabrizio Vincenzi, et al.
Arthritis Research & Therapy|August 28, 2016
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosusAlessandra Bortoluzzi, Fabrizio Vincenzi, Marcello Govoni, et al.
Pageof 24